LivaNova (LIVN)
40.41
0.93 (2.36%)
At close: Mar 24, 2025, 3:59 PM
41.07
1.63%
After-hours: Mar 24, 2025, 07:54 PM EDT
2.36% (1D)
| Bid | 39.99 |
| Market Cap | 2.2B |
| Revenue (ttm) | 1.25B |
| Net Income (ttm) | 63.18M |
| EPS (ttm) | 1.16 |
| PE Ratio (ttm) | 34.84 |
| Forward PE | 13.91 |
| Analyst | Buy |
| Ask | 42.14 |
| Volume | 468,331 |
| Avg. Volume (20D) | 637,306 |
| Open | 40.63 |
| Previous Close | 39.48 |
| Day's Range | 40.08 - 40.88 |
| 52-Week Range | 36.85 - 64.47 |
| Beta | 1.11 |
About LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The ...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 19, 2015
Employees 2,900
Stock Exchange NASDAQ
Ticker Symbol LIVN
Website https://www.livanova.com
Analyst Forecast
According to 6 analyst ratings, the average rating for LIVN stock is "Buy." The 12-month stock price forecast is $60, which is an increase of 48.48% from the latest price.
Stock ForecastsNext Earnings Release
LivaNova is scheduled to release its earnings on Apr 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+5.53%
LivaNova shares are trading higher. Needham reiter...
Unlock content with
Pro Subscription
4 weeks ago
-15.76%
LivaNova shares are trading lower after the company reported Q4 sales below estimates.
